FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3173541931> ?p ?o ?g. }

• W3173541931 endingPage "578" @default.
• W3173541931 startingPage "574" @default.
• W3173541931 abstract "Corpora amylacea (CA) is usually present in benign prostatic ducts and acini, and its presence is considered suggestive of negative or low-risk prostate cancer. The clinicopathological definition of CA among prostate cancer cells (CAPCCs)—described as CA entirely surrounded by invasive cancer cells—has not been discussed. As intraductal carcinoma of the prostate (IDC-P) is a well-known adverse prognostic factor in prostate cancer, this study aimed to elucidate the relationship between CAPCC and IDC-P. We enrolled 366 patients who underwent robotic-assisted radical prostatectomies between 2012 and 2018 at Aichi Medical University Hospital. All surgical specimens were independently reviewed by two genitourinary pathologists. The median age of the patients was 68.5 years; the median serum prostate-specific antigen was 6.49 ng/mL. IDC-P was observed in 143 (39.1%) patients, while the presence of CAPCC was observed in 47 cases (12.8%). Patients with CAPCC were associated with more advanced clinical and pathological T stages, as well as Gleason scores, than those without CAPCC (p=0.018, p<0.001, p=0.036). Notably, the presence of CAPCC was significantly associated with the presence of IDC-P (39 cases) and a high Gleason score compared with the absence of CAPCC (12 cases) (p<0.001 and p=0.036, respectively). The presence of CAPCC is an adverse pathological feature, often closely related to IDC-P. Therefore, CAPCC may be a surrogate finding to detect IDC-P via haematoxylin and eosin staining. Corpora amylacea (CA) is usually present in benign prostatic ducts and acini, and its presence is considered suggestive of negative or low-risk prostate cancer. The clinicopathological definition of CA among prostate cancer cells (CAPCCs)—described as CA entirely surrounded by invasive cancer cells—has not been discussed. As intraductal carcinoma of the prostate (IDC-P) is a well-known adverse prognostic factor in prostate cancer, this study aimed to elucidate the relationship between CAPCC and IDC-P. We enrolled 366 patients who underwent robotic-assisted radical prostatectomies between 2012 and 2018 at Aichi Medical University Hospital. All surgical specimens were independently reviewed by two genitourinary pathologists. The median age of the patients was 68.5 years; the median serum prostate-specific antigen was 6.49 ng/mL. IDC-P was observed in 143 (39.1%) patients, while the presence of CAPCC was observed in 47 cases (12.8%). Patients with CAPCC were associated with more advanced clinical and pathological T stages, as well as Gleason scores, than those without CAPCC (p=0.018, p<0.001, p=0.036). Notably, the presence of CAPCC was significantly associated with the presence of IDC-P (39 cases) and a high Gleason score compared with the absence of CAPCC (12 cases) (p<0.001 and p=0.036, respectively). The presence of CAPCC is an adverse pathological feature, often closely related to IDC-P. Therefore, CAPCC may be a surrogate finding to detect IDC-P via haematoxylin and eosin staining." @default.
• W3173541931 created "2021-07-05" @default.
• W3173541931 creator A5018868776 @default.
• W3173541931 creator A5034433475 @default.
• W3173541931 creator A5056325561 @default.
• W3173541931 creator A5056557726 @default.
• W3173541931 creator A5070100769 @default.
• W3173541931 date "2021-08-01" @default.
• W3173541931 modified "2023-09-27" @default.
• W3173541931 title "Presence of corpora amylacea among prostate cancer cells: an unrecognised feature of intraductal carcinoma of the prostate" @default.
• W3173541931 cites W1689742823 @default.
• W3173541931 cites W1901104231 @default.
• W3173541931 cites W1914128856 @default.
• W3173541931 cites W1989602328 @default.
• W3173541931 cites W2013217410 @default.
• W3173541931 cites W2023757988 @default.
• W3173541931 cites W2035528720 @default.
• W3173541931 cites W2075296303 @default.
• W3173541931 cites W2082917222 @default.
• W3173541931 cites W2095421687 @default.
• W3173541931 cites W2099194261 @default.
• W3173541931 cites W2104022977 @default.
• W3173541931 cites W2112634319 @default.
• W3173541931 cites W2117792530 @default.
• W3173541931 cites W2143814249 @default.
• W3173541931 cites W2229746266 @default.
• W3173541931 cites W2511755939 @default.
• W3173541931 cites W2620798309 @default.
• W3173541931 cites W2794415932 @default.
• W3173541931 cites W2807619177 @default.
• W3173541931 cites W2884076176 @default.
• W3173541931 cites W2889292086 @default.
• W3173541931 cites W2901653975 @default.
• W3173541931 cites W2912387879 @default.
• W3173541931 cites W2946803574 @default.
• W3173541931 cites W2995148260 @default.
• W3173541931 cites W2999417355 @default.
• W3173541931 cites W3000095444 @default.
• W3173541931 cites W3015540184 @default.
• W3173541931 cites W4211140416 @default.
• W3173541931 cites W4214806444 @default.
• W3173541931 cites W43791740 @default.
• W3173541931 doi "https://doi.org/10.1016/j.pathol.2020.09.033" @default.
• W3173541931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34154844" @default.
• W3173541931 hasPublicationYear "2021" @default.
• W3173541931 type Work @default.
• W3173541931 sameAs 3173541931 @default.
• W3173541931 citedByCount "0" @default.
• W3173541931 crossrefType "journal-article" @default.
• W3173541931 hasAuthorship W3173541931A5018868776 @default.
• W3173541931 hasAuthorship W3173541931A5034433475 @default.
• W3173541931 hasAuthorship W3173541931A5056325561 @default.
• W3173541931 hasAuthorship W3173541931A5056557726 @default.
• W3173541931 hasAuthorship W3173541931A5070100769 @default.
• W3173541931 hasConcept C121608353 @default.
• W3173541931 hasConcept C126322002 @default.
• W3173541931 hasConcept C126894567 @default.
• W3173541931 hasConcept C133507102 @default.
• W3173541931 hasConcept C142724271 @default.
• W3173541931 hasConcept C143998085 @default.
• W3173541931 hasConcept C204232928 @default.
• W3173541931 hasConcept C207886595 @default.
• W3173541931 hasConcept C2776235491 @default.
• W3173541931 hasConcept C2776919888 @default.
• W3173541931 hasConcept C2777546739 @default.
• W3173541931 hasConcept C2780192828 @default.
• W3173541931 hasConcept C71924100 @default.
• W3173541931 hasConceptScore W3173541931C121608353 @default.
• W3173541931 hasConceptScore W3173541931C126322002 @default.
• W3173541931 hasConceptScore W3173541931C126894567 @default.
• W3173541931 hasConceptScore W3173541931C133507102 @default.
• W3173541931 hasConceptScore W3173541931C142724271 @default.
• W3173541931 hasConceptScore W3173541931C143998085 @default.
• W3173541931 hasConceptScore W3173541931C204232928 @default.
• W3173541931 hasConceptScore W3173541931C207886595 @default.
• W3173541931 hasConceptScore W3173541931C2776235491 @default.
• W3173541931 hasConceptScore W3173541931C2776919888 @default.
• W3173541931 hasConceptScore W3173541931C2777546739 @default.
• W3173541931 hasConceptScore W3173541931C2780192828 @default.
• W3173541931 hasConceptScore W3173541931C71924100 @default.
• W3173541931 hasIssue "5" @default.
• W3173541931 hasLocation W31735419311 @default.
• W3173541931 hasLocation W31735419312 @default.
• W3173541931 hasOpenAccess W3173541931 @default.
• W3173541931 hasPrimaryLocation W31735419311 @default.
• W3173541931 hasRelatedWork W1980245127 @default.
• W3173541931 hasRelatedWork W2033603622 @default.
• W3173541931 hasRelatedWork W2127440557 @default.
• W3173541931 hasRelatedWork W2129122136 @default.
• W3173541931 hasRelatedWork W2347956231 @default.
• W3173541931 hasRelatedWork W2350150832 @default.
• W3173541931 hasRelatedWork W2463033561 @default.
• W3173541931 hasRelatedWork W2897445903 @default.
• W3173541931 hasRelatedWork W2977461741 @default.
• W3173541931 hasRelatedWork W3029310622 @default.
• W3173541931 hasVolume "53" @default.
• W3173541931 isParatext "false" @default.
• W3173541931 isRetracted "false" @default.

• next